Acute heart transplant rejection due to Saint John's wort.

By F. Ruschitzka, Peter J. Meier, M. Turina, T. Lüscher, G. Noll. The Lancet, 2000

690 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties (2001, background): “…(Yue et al 2000) and published case reports (Rey & Walter 1998; Nebel et al 1999; Barone et al 2000; Breidenbach et al 2000; Piscitelli et al 2000; Ruschitzka et al 2000) of interactions between St John’s wort and certain prescribed medicines, leading to a loss of or reduction in therapeutic…”
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. (2018, background): “John’s wort, although relevant interactions have been published (also outside the anticoagulation field).(169) Due to the relevant decrease in NOAC levels, the concomitant use of St.”
Interactions Between Herbal Medicines and Prescribed Drugs (2012, neutral): “We found 128 cases of herb-drug interactions (108 for St John’s wort, 8 for ginkgo, 6 for garlic, 3 for ginseng and 3 for kava) in 52 publications.([24-75]) No cases of interactions were found for echinacea and saw palmetto.”